L26/P-712 The role of inflammation in infertility: an observational proteomic study of women with chronic kidney disease (CKD) compared to healthy controls
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Bhaduri und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question How do circulating inflammatory proteins in CKD affect ovarian reserve and reproductive potential? Summary answer 61 inflammatory proteins were associated with AMH and AFC, which were not raised in immunosuppressed transplant patients; suggesting inflammation is a driving factor in infertility What is known already Chronic kidney disease (CKD) affects up to 6% of women of reproductive age and is associated with reduced fertility, yet underlying mechanisms remain poorly understood. Chronic inflammation and oxidative stress, hallmarks of CKD, are known to disrupt reproductive function. Proteomic approaches provide valuable biological insight, capturing dynamic protein expression changes in response to disease and environmental factors. Emerging evidence links dysregulated inflammatory and oxidative stress pathways to both CKD and infertility. However, circulating inflammatory proteins in CKD have not been studied in relation to ovarian reserve or reproductive hormones. This study addresses this knowledge gap using proteomic analysis. Study design, size, duration This observational cohort study recruited participants from four tertiary hospitals over one year. Participants attended a single study visit, scheduled between cycle days 1–5 when menstruating. Demographic, medical, and detailed gynaecological histories were collected and prior medical records reviewed. Biomarkers included proteomics (measured using the antibody-based Olink Explore 3072 inflammation panel for 368 proteins), fertility markers, reproductive hormones, and renal function. All participants underwent a fertility assessment scan and provided written informed consent (IRAS 285546). Participants/materials, setting, methods Ovarian reserve was assessed using antral follicle count (AFC) and anti-Müllerian hormone (AMH). Secondary analyses examined reproductive hormones including FSH, LH, oestrogen, progesterone, prolactin, and testosterone. Adjusted linear regression models assessed associations between protein expression and outcomes in the overall CKD cohort, transplant recipients, and healthy controls. Models adjusted for age, BMI, eGFR, diabetes, and dialysis/transplant status. Analyses were corrected for multiple comparison (FDR 5%), with STRING used for pathway annotation and gene ontology enrichment. Main results and the role of chance The study included 101 women with CKD and 56 healthy controls, including 22 immunosuppressed participants with kidney transplants. The cohorts were matched for age and body mass index. Fertility assessment demonstrated lower AMH concentrations in participants with CKD compared with controls (13.6 vs. 23.5 pmol/L, p = 0.005), and AFC tended to be lower but was not significant(12.5 vs. 18.0,p=0.08). LH levels were higher in women with CKD(5.8 vs. 4.3IU/L, p < 0.001), while testosterone levels were lower(0.5 vs. 0.7nmol/L,p=0.002). Proteomic analysis identified 58 significant proteins associated with decreased AFC and 48 proteins associated with reduced AMH in participants with CKD and one protein (DNER) was associated with increased AFC. In the control cohort, CXCL8 associated with increased AFC. The highest biological process gene ontology enrichment in participants with CKD were positive regulation of cytokine production and tumour necrosis factor–mediated signalling pathways. Increased WAS (Wiskott–Aldrich Syndrome) protein expression associated with reduced oestrogen levels in participants with CKD, with enrichment of actin filament–based processes. CDON, IDS, and ITGA11 associated with increased testosterone levels, with cell adhesion pathways predominating. In controls, increased CD244 associated with reduced progesterone, enriched for regulation of natural killer cell-mediated immunity. No significant proteomic associations were observed in the transplant subgroup. Limitations, reasons for caution Similar to many proteomic studies, this study is limited by a lack of ethnic diversity, despite efforts to include participants from non-White backgrounds. As this work is hypothesis-generating rather than designed to establish causality, further large-scale studies are required to investigate the causal role of inflammation in subfertility. Wider implications of the findings This is the first proteomic study to investigate infertility in women with a chronic medical condition such as CKD. CKD is characterised by inflammatory proteins strongly associated with reduced ovarian reserve, particularly TNF-related superfamily proteins, which represent promising non-invasive biomarkers and potential therapeutic targets due to their cell-surface localisation. Trial registration number Yes
Zitieren
APA
Bhaduri, M., Morley, A., Ardissino, M., Nicolaides, K., Sarris, I., & Bramham, K. (2026). L26/P-712 The role of inflammation in infertility: an observational proteomic study of women with chronic kidney disease (CKD) compared to healthy controls. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1041
Vancouver
Bhaduri M, Morley A, Ardissino M, Nicolaides K, Sarris I, Bramham K. L26/P-712 The role of inflammation in infertility: an observational proteomic study of women with chronic kidney disease (CKD) compared to healthy controls. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1041
BibTeX
@article{Bhaduri2026,
author = {Bhaduri, M. and Morley, A. and Ardissino, M. and Nicolaides, K. and Sarris, I. and Bramham, K.},
title = {L26/P-712 The role of inflammation in infertility: an observational proteomic study of women with chronic kidney disease (CKD) compared to healthy controls},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1041}
}
EUVIMED